| Net Cash Provided by (Used in) Operating Activities |
$341,803 |
USD |
83% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$204,128 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$32,319,726 |
USD |
|
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
700,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
168,631,209 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$63,327,263 |
USD |
458% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,332,345 |
USD |
55% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$1,332,794 |
USD |
45% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$750,731 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$56,503 |
USD |
42% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2024 |
Q3 2024 |
| Additional Paid in Capital |
$704,982 |
USD |
9.2% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |